Armata Pharmaceuticals, Inc

ARMPAMEX · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

37.1M

on 2026-06-30, from 36.2M on 2025-09-30 10-Q ↗

Earlier counts are adjusted for the 10-for-1 split; each bar's tip shows the count as filed.

Counts before 2025-09-30 are left out: the count went from 361.9M on 2025-06-30 to 36.2M on 2025-09-30, a change no split on file explains.

Newest

$100.0M

S-3 of 2025-08-13. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

JonesTrading Institutional Services, agreement of 2025-12-01. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

10.66M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

3.8 quarters

$24.0M on 2026-06-30 ÷ $6.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 1 of its filings are not read yet.